IL6R and myeloid sarcoma: Considering the potential pleiotropic effect of rs643434 which located at the complex ABO region, the relationship between IL-6 and MS risk was also estimated using the single SNP rs56383622 located at IL6R; there was suggestive evidence demonstrating that elevated levels of IL-6 were associated with lower risk of MS (OR, 0.87; 95% CI, 0.75–1.00; p =0.047).